Archive - 2017 - June | Nordic Life Science Insight

2017

-

June

Date

Title

Category

Company

June 7, 2017

FDA Approves New Novo Nordisk Treatment for Patients with Hemophilia

Novo Nordisk Pharmatech A/S

June 8, 2017

Spago Nanomedical and Charles River Laboratories announce agreement for preclinical studies of SpagoPix

Spago Nanomedical

June 9, 2017

Spago Nanomedical appoints product candidate in the SpagoPix-project

Spago Nanomedical

June 12, 2017

Xultophy® 100/3.6 demonstrated similar A1C reductions with significantly lower rates of hypoglycemia and a decrease in weight vs basal-bolus therapy

Novo Nordisk Pharmatech A/S

June 16, 2017

SpagoPix product patent approved in Japan

Spago Nanomedical

June 19, 2017

SpagoPix promising results in toxicological pilot studies

Spago Nanomedical

June 19, 2017

FDA posts briefing materials prior to Advisory Committee meeting for Victoza® label update

Novo Nordisk Pharmatech A/S

June 20, 2017

Spago Nanomedical and Charles River Laboratories announce agreement for preclinical studies of SpagoPix

Spago Nanomedical

June 21, 2017

Novo Nordisk receives positive 17-2 vote from FDA Advisory Committee that Victoza® provides substantial evidence of cardiovascular risk reduction in patients with type 2 diabetes

Spago Nanomedical

June 21, 2017

InDex Pharmaceuticals enrolls first patient in the phase IIb study CONDUCT with cobitolimod

InDex Pharmaceuticals

June 23, 2017

Opening a new door to cell and gene therapy accessible to all

Medicon Village AB

June 26, 2017

20 Years anniversary medicon valley alliance

Medicon Valley Alliance

June 29, 2017

International Collaboration in Cancer Innovation

Oslo Cancer Cluster

Tweets by NLSInsight